Douglas Kerr
Chief Medical Officer · 3 filings · Latest: May 13, 2026
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DYN | Douglas Kerr | Chief Medical Officer | May 13, 2026 | Sale | $18.36 | 1,564 | $28.7K | 170,042 | |
DYN | Douglas Kerr | Chief Medical Officer | Mar 5, 2026 | Sale | $14.90 | 904 | $13.5K | 171,606 | |
DYN | Kerr Douglas | — | Dec 5, 2025 | Proposed Sale | $20.72 | 880 | $18.2K | — | |
DYN | Kerr Douglas | — | Sep 4, 2025 | Proposed Sale | $13.27 | 4,552 | $60.4K | — | |
DYN | Kerr Douglas | — | Jun 5, 2025 | Proposed Sale | $13.35 | 1,342 | $17.9K | — | |
DYN | Kerr Douglas | — | Mar 5, 2025 | Proposed Sale | $11.89 | 1,343 | $16.0K | — |